Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook

assets and liabilities (3,181) (3,808)

Total adjustments 286,148 916,370

Net cash provided by

operating activities 427,178 471,365

Cash Flows from Investing Activities:

Additions to property, equipment and

product rights (75,870) (45,028)

Acquisition of business, net of cash

acquired - (1,558,322)

Additions to marketable securities

and long-term investments (8,451) (18,835)

Proceeds from sale of marketable

securities and investments 4,113 158,185

Other investing activities, net 15,916 44,581

Net cash used in investing

activities (64,292) (1,419,419)

Cash Flows from Financing Activities:

Proceeds from issuance of long-term debt - 650,000

Payments on term loan, current debt

and other long-term liabilities (329,532) (23,363)

Proceeds from stock plans 16,160 8,137

Other 869 -

Net cash (used in) provided

by financing activities (312,503) 634,774

Net increase (decrease) in

cash and cash equivalents 50,383 (313,280)

Cash and cash equivalents at

beginning of period 154,171 467,451

Cash and cash equivalents at end of

period $204,554 $154,171

The following table presents a reconciliation of reported net income and diluted earnings per diluted share

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
(Date:7/20/2014)... fuel gets recycled, the process releases radioactive krypton and ... with the related gas radon. A new porous material ... July 20 in Nature Materials shows how: ... not out. , The CC3 material could be ... nuclear fuel or air in buildings and also in ...
(Date:7/18/2014)... Urbana-Champaign have demonstrated that an array of novel ... traditional photographic film to record light for distances ... light (for example, distances less than ~600 nm ... as a "nanocamera" whereas the pBNAs are the ... effect (writing and curing) is seen in real ...
(Date:7/18/2014)... Nuclear Power Countries - Market Forecast, Key Companies and ... report from GlobalData, Emerging Nuclear Power Countries - Market ... the emerging nuclear market and the key factors affecting ... players and their global market share. The market value ... has also been estimated. , To browse a full ...
(Date:7/17/2014)... 17, 2014  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... development and commercialization of products for the treatment of ... results for the second quarter of 2014 on Thursday, ... The Company will host a conference call at ... which Vanda management will discuss the second quarter 2014 ...
Breaking Biology Technology:A noble gas cage 2A noble gas cage 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2
... Milwaukee As the highway reconstruction ... leveled at the amount of money, $685,000, spent on a ... , ,The Web site for the Marquette Interchange Project ... a joint venture between the consultants working on the interchange, ...
... sell advertising to competitors of Geico Corp. who use ... court in Virginia has ruled. Advertising based on Web ... Googles business. In the third quarter, about half of ... also called sponsored links. , ,This case involved ...
... companies out there will give you a logo at no cost, ... free Web site. I guess the nextbig thing will be that ... and how are they doing this? , ,The Internet has removed ... issues in real time without the fancy decorum and the big-time ...
Cached Biology Technology:$685,000 too much for construction Web site, critics say 2$685,000 too much for construction Web site, critics say 3Google wins first battle in trademark war 2Free branding? Why not? 2Free branding? Why not? 3
(Date:7/21/2014)... by neurobiologist Luke Remage-Healey at the University of ... the brains of young birds enhance their ability ... development. This period has a parallel to universal ... separate study, the UMass Amherst neuroscientist and colleagues ... the brain,s auditory cortex enhances the representation of ...
(Date:7/21/2014)... runoff is causing problems for the world,s water ... Agency found stormwater runoff to be one of ... rivers, streams, lakes, ponds, reservoirs, bays, and estuaries. ... fish and wildlife populations, foul drinking water, and ... Carolina State University are looking to rain gardens ...
(Date:7/21/2014)... Cystoid macular edema (CME) is a common complication ... in which patients typically lose night and side vision ... also decrease central vision. Current treatments for CME in ... adverse results. , Researchers from the Massachusetts Eye and ... Medicine tested whether the extent of retinal swelling due ...
Breaking Biology News(10 mins):Studying estrogens made by the brain may offer new insights in learning and memory 2Studying estrogens made by the brain may offer new insights in learning and memory 3Filter bed substrates, plant types recommended for rain gardens 2Iodine may alleviate swelling in retinitis pigmentosa patients' retinas 2
... have much in common with a Rottweiler, you might be ... a cave in the Altai Mountains of Siberia for 33,000 ... domestication and, together with equally ancient dog remains from a ... occurred repeatedly in different geographic locations rather than with a ...
... is available in German . Mate ... animal species. During mating season male testosterone levels rise, ... features. Male bonobos, however, invest much more into friendly ... collide with this increased tendency towards forming pair-relationships. ...
... 26 million Americans with diabetes, drawing blood is the ... invasive and at least minimally painful. Researchers at Brown ... check blood sugar levels by measuring glucose concentrations in ... convergence of nanotechnology and surface plasmonics, which explores the ...
Cached Biology News:Dog skull dates back 33,000 years 2Dog skull dates back 33,000 years 3Bonobos' unusual success story 2Biochip measures glucose in saliva, not blood 2Biochip measures glucose in saliva, not blood 3
Request Info...
Incorporating the innovative InGaAs detection system the Cary 6000i is the worlds most advanced UV-Vis-NIR spectrophotometer delivering superior signal to noise performance and outstanding sensitivit...
The pYES2 vector is designed for native expression of your protein of interest in S. cerevisiae. It contains the URA3 gene for selection in yeast and 2 origin for high-copy maintenance....
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
Biology Products: